AVEO Oncology
AVEO
#7473
Rank
NZ$0.93 B
Marketcap
NZ$26.75
Share price
0.00%
Change (1 day)
172.55%
Change (1 year)

Earnings for AVEO Oncology (AVEO)

Earnings in 2022 (TTM): -NZ$44.46 Million

According to AVEO Oncology 's latest financial reports the company's current earnings are NZ$94.31 Million. In 2021 the company made an earning of -NZ$95.15 Million a decrease over its 2020 earnings that were of -NZ$63.47 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for AVEO Oncology from 2009 to 2022

Annual earnings

Year Earnings Change
2022 (TTM) -NZ$44.46 Million-53.27%
2021 -NZ$95.15 Million49.9%
2020 -NZ$63.47 Million-479.04%
2019 NZ$16.74 M-276.17%
2018 -NZ$9.51 Million-91.79%
2017 -NZ$0.12 Billion142.38%
2016 -NZ$47.78 Million78.51%
2015 -NZ$26.77 Million-71.55%
2014 -NZ$94.07 Million-50.72%
2013 -NZ$0.2 Billion-4.88%
2012 -NZ$0.21 Billion-426.29%
2011 NZ$61.5 M-159.85%
2010 -NZ$0.11 Billion35.33%
2009 -NZ$75.95 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Eli Lilly
LLY
NZ$62.01 B-119,832.77%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
NZ$19.71 B-38,159.16%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
NZ$0.79 B-1,632.77%๐Ÿ‡บ๐Ÿ‡ธ USA
Regeneron Pharmaceuticals
REGN
NZ$10.14 B-19,683.32%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
NZ$20.21 B-39,123.38%๐Ÿ‡บ๐Ÿ‡ธ USA
Merrimack Pharmaceuticals
MACK
-NZ$4.03 Million-92.22%๐Ÿ‡บ๐Ÿ‡ธ USA